tradingkey.logo

Embecta Corp

EMBC
View Detailed Chart
12.080USD
+0.160+1.34%
Close 12/24, 13:00ETQuotes delayed by 15 min
706.63MMarket Cap
7.38P/E TTM

Embecta Corp

12.080
+0.160+1.34%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.34%

5 Days

+1.60%

1 Month

-17.09%

6 Months

+23.01%

Year to Date

-41.50%

1 Year

-40.76%

View Detailed Chart

TradingKey Stock Score of Embecta Corp

Currency: USD Updated: 2025-12-23

Key Insights

Embecta Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 54/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 16.67.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Embecta Corp's Score

Industry at a Glance

Industry Ranking
54 / 208
Overall Ranking
136 / 4568
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Hold
Current Rating
16.667
Target Price
+50.83%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Embecta Corp Highlights

StrengthsRisks
Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.08B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 38.36%.
Undervalued
The company’s latest PE is 7.29, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 58.75M shares, decreasing 0.01% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 1.05K shares of this stock.

Embecta Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Embecta Corp Info

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
Ticker SymbolEMBC
CompanyEmbecta Corp
CEOKurdikar (Devdatt)
Websitehttps://www.embecta.com/

FAQs

What is the current price of Embecta Corp (EMBC)?

The current price of Embecta Corp (EMBC) is 12.080.

What is the symbol of Embecta Corp?

The ticker symbol of Embecta Corp is EMBC.

What is the 52-week high of Embecta Corp?

The 52-week high of Embecta Corp is 21.230.

What is the 52-week low of Embecta Corp?

The 52-week low of Embecta Corp is 9.200.

What is the market capitalization of Embecta Corp?

The market capitalization of Embecta Corp is 706.63M.

What is the net income of Embecta Corp?

The net income of Embecta Corp is 95.40M.

Is Embecta Corp (EMBC) currently rated as Buy, Hold, or Sell?

According to analysts, Embecta Corp (EMBC) has an overall rating of Hold, with a price target of 16.667.

What is the Earnings Per Share (EPS TTM) of Embecta Corp (EMBC)?

The Earnings Per Share (EPS TTM) of Embecta Corp (EMBC) is 1.636.
KeyAI